• Title of article

    Studies on the non-pathogenicity of Chryseobacterium proteolyticum and on the safety of the enzyme: Protein–glutaminase

  • Author/Authors

    Scheuplein، نويسنده , , Robert J. and Mizutani، نويسنده , , Atsushi and Yamaguchi، نويسنده , , Shotaro، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2007
  • Pages
    11
  • From page
    79
  • To page
    89
  • Abstract
    Protein–glutaminase (PG) is a protein-deamidating enzyme produced from the microorganism Chryseobacterium proteolyticum strain 9670. Food safety studies were conducted on both the enzyme and the production organism. The strain was evaluated for pathogenicity and toxigenicity by intravenous and oral inoculation studies in Slc:ICR male SPF mice. The results demonstrate that the tested C. proteolyticum strain is of very low pathogenicity comparable to known food source bacterial strains and is very unlikely to demonstrate any pathogenicity in animals or humans. The level of endotoxin is very low and typical of the endotoxin levels in drinking water and teas. A 90-day study of PG, conducted in Sprague–Dawley rats, showed no adverse effects due to the enzyme up to dose levels of 2500 mg/kg-bw/day (NOAEL). Details of the study are presented, including, organ and body weights, histological findings, and blood and urine chemistry. Additionally, bacterial reverse mutation test (Ames test) and chromosomal aberration test using mammalian established cell line were conducted, resulting in the absence of mutagenicity in PG.
  • Keywords
    Mutagenicity , pathogenicity , Enzyme , Food safety , Protein–glutaminase , 90-day rat study , Chryseobacterium proteolyticum
  • Journal title
    Regulatory Toxicology and Pharmacology
  • Serial Year
    2007
  • Journal title
    Regulatory Toxicology and Pharmacology
  • Record number

    1488052